Achievement of long-term local control after radiation and anti-PD-1 immunotherapy in locally advanced non-small cell lung cancer

Although concurrent chemoradiotherapy (CRT) is recommended as standard of care in patients with locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC), many patients who refuse or are not eligible for chemotherapy received radiotherapy (RT) alone with 5-year overall survival (O...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Zhao, Zhou, Rongjin, Zhang, Ni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482707/
https://www.ncbi.nlm.nih.gov/pubmed/34729152
http://dx.doi.org/10.1177/20406223211047306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482707/
https://www.ncbi.nlm.nih.gov/pubmed/34729152
http://dx.doi.org/10.1177/20406223211047306

Ejemplares similares